Skip to main content
Erschienen in: Urolithiasis 5/2005

01.11.2005 | Original Paper

Insights on the pathology of kidney stone formation

verfasst von: Andrew P. Evan, Fredric L. Coe, James E. Lingeman, Elaine Worcester

Erschienen in: Urolithiasis | Ausgabe 5/2005

Einloggen, um Zugang zu erhalten

Abstract

The purpose of these studies was to test the hypothesis that Randall’s plaque develops in unique anatomical sites of the kidney and that its formation is conditioned by specific stone-forming pathophysiologies. To test this hypothesis, we performed intraoperative mapping studies with biopsies of papilla from the kidneys of 15 idiopathic calcium oxalate (CaOx) stone formers, four intestinal bypass for obesity patients and ten brushite stone formers, and obtained papillary specimens from four non-stone formers after nephrectomy. Both light and electron microscopic examination of tissue changes along with infrared and electron diffraction analyses of mineral composition were performed. Distinct patterns of mineral deposition and papillary pathology were discovered in each of the three different stone forming groups. CaOx stone formers had predictable sites of interstitial apatite crystals beginning at the thin loops of Henle and spreading to the urothelium. These plaque areas are termed Randall’s plaque and are thought to serve as sites for stone attachment. The papilla and medullary tubules appeared normal. The intestinal bypass patients only had intraluminal sites of crystalline material in the medullary collecting ducts. The brushite stone formers had the most severe form of cortical and medullary changes with sites of Randall’s plaque, and yellowish intraluminal deposits in medullary collecting ducts. All deposits were determined to be apatite. The metabolic and surgical pathologic finding in three distinct groups of stone formers clearly shows that “the histology of the renal papilla from a stone former is particular to the clinical setting”. It is observations like these that we believe will provide the insights to allow the stone community to generate better clinical treatments for kidney stone disease, as we understand the pathogenesis of stone formation for each type of stone former.
Literatur
1.
Zurück zum Zitat Shuster J, Scheaffer RL (1984) Economic impact of kidney stones in white male adults. Urology 24: 327CrossRefPubMed Shuster J, Scheaffer RL (1984) Economic impact of kidney stones in white male adults. Urology 24: 327CrossRefPubMed
2.
Zurück zum Zitat Parks JH, Coe FL (1996) The financial effects of kidney stone prevention. Kidney Int 50: 1706PubMed Parks JH, Coe FL (1996) The financial effects of kidney stone prevention. Kidney Int 50: 1706PubMed
3.
Zurück zum Zitat Lingeman JE, Coury TA, Newman DM et al. (1987) Comparison of results and morbidity of percutaneous nephrostolithotomy and extracorporeal shock wave lithotripsy. J Urol 138: 485PubMed Lingeman JE, Coury TA, Newman DM et al. (1987) Comparison of results and morbidity of percutaneous nephrostolithotomy and extracorporeal shock wave lithotripsy. J Urol 138: 485PubMed
4.
Zurück zum Zitat Parks JH, Coe FL (1994) An increasing number of calcium oxalate stone events worsens treatment outcome. Kidney Int 45: 1722PubMed Parks JH, Coe FL (1994) An increasing number of calcium oxalate stone events worsens treatment outcome. Kidney Int 45: 1722PubMed
5.
Zurück zum Zitat Khan SR (1991) Pathogenesis of oxalate urolithiasis: lessons from experimental studies with rats. Am J Kidney Dis 17: 398PubMed Khan SR (1991) Pathogenesis of oxalate urolithiasis: lessons from experimental studies with rats. Am J Kidney Dis 17: 398PubMed
6.
Zurück zum Zitat Randall A (1937) The origin and growth of renal calculi. Ann Surg 105: 1009 Randall A (1937) The origin and growth of renal calculi. Ann Surg 105: 1009
7.
Zurück zum Zitat Asplin JR, Parks JH, Coe FL (1997) Dependence of upper limit of metastability on supersaturation in nephrolithiasis. Kidney Int 52: 1602PubMed Asplin JR, Parks JH, Coe FL (1997) Dependence of upper limit of metastability on supersaturation in nephrolithiasis. Kidney Int 52: 1602PubMed
8.
Zurück zum Zitat Low RK, Stoller ML (1997) Endoscopic mapping of renal papillae for Randall’s plaques in patients with urinary stone disease. J Urol 158: 2062PubMed Low RK, Stoller ML (1997) Endoscopic mapping of renal papillae for Randall’s plaques in patients with urinary stone disease. J Urol 158: 2062PubMed
9.
Zurück zum Zitat Evan AP, Lingeman JE, Coe FL et al. (2003) Randall’s plaque of patients with nephrolithiasis begins in basement membrane of thin loops of Henle. JCI 111: 607CrossRefPubMed Evan AP, Lingeman JE, Coe FL et al. (2003) Randall’s plaque of patients with nephrolithiasis begins in basement membrane of thin loops of Henle. JCI 111: 607CrossRefPubMed
10.
Zurück zum Zitat Kuo RL, Lingeman JE, Evan AP et al. (2003) Urine calcium and volume predict coverage of renal papilla by Randall’s plaque. Kidney Int 64: 2150CrossRefPubMed Kuo RL, Lingeman JE, Evan AP et al. (2003) Urine calcium and volume predict coverage of renal papilla by Randall’s plaque. Kidney Int 64: 2150CrossRefPubMed
11.
Zurück zum Zitat Kim SC, Coe FL, Tinmouth WW et al. (2005) Stone formation is proportionally to papillary surface coverage by Randall’s plaque. J Urol 173: 117PubMed Kim SC, Coe FL, Tinmouth WW et al. (2005) Stone formation is proportionally to papillary surface coverage by Randall’s plaque. J Urol 173: 117PubMed
12.
Zurück zum Zitat Khan SR, Hackett RL (1987) Crystal-matrix relationships in experimentally induced urinary calcium oxalate monohydrate crystals, an ultrastructural study. Calcif Tissue Int 41: 157PubMed Khan SR, Hackett RL (1987) Crystal-matrix relationships in experimentally induced urinary calcium oxalate monohydrate crystals, an ultrastructural study. Calcif Tissue Int 41: 157PubMed
13.
Zurück zum Zitat Khan SR, Kok DJ (2004) Modulators of urinary stone formation. Frontiers Biosci 9: 1450 Khan SR, Kok DJ (2004) Modulators of urinary stone formation. Frontiers Biosci 9: 1450
14.
Zurück zum Zitat Evan AAP, Coe FL, Rittling SR et al. (2005) Apatite plaque particles in inner medulla of kidneys of CaOx stone formers: Osteopontin localization. Kidney Intl (in press) Evan AAP, Coe FL, Rittling SR et al. (2005) Apatite plaque particles in inner medulla of kidneys of CaOx stone formers: Osteopontin localization. Kidney Intl (in press)
15.
Zurück zum Zitat Evan AP, Lingeman JE, Coe FL et al. (2005) Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int 67: 576CrossRefPubMed Evan AP, Lingeman JE, Coe FL et al. (2005) Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int 67: 576CrossRefPubMed
Metadaten
Titel
Insights on the pathology of kidney stone formation
verfasst von
Andrew P. Evan
Fredric L. Coe
James E. Lingeman
Elaine Worcester
Publikationsdatum
01.11.2005
Verlag
Springer-Verlag
Erschienen in
Urolithiasis / Ausgabe 5/2005
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-005-0488-0

Weitere Artikel der Ausgabe 5/2005

Urolithiasis 5/2005 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.